EGTX — Egetis Therapeutics AB (publ) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Egetis Therapeutics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	144	128	303	351	216
Net Total Accounts Receivable
Net Total Receivables	6.8	10.2	36.4	23.6	27.9
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	153	147	346	380	254
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.28	2.7	4.4	2.6	9.7
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	569	561	760	792	639
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	39.2	49.4	104	204	241
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	42.2	54.9	215	299	300
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	527	506	546	493	339
Total Liabilities & Shareholders' Equity	569	561	760	792	639
Total Common Shares Outstanding